➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Express Scripts
Medtronic
Johnson and Johnson
McKesson

Last Updated: May 29, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Amdoxovir


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Amdoxovir?

Amdoxovir is an investigational drug.

There have been 5 clinical trials for Amdoxovir. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2012.

The most common disease conditions in clinical trials are HIV Infections, Acquired Immunodeficiency Syndrome, and Virus Diseases. The leading clinical trial sponsors are RFS Pharma, LLC, National Institute of Allergy and Infectious Diseases (NIAID), and [disabled in preview].

There are five hundred and one US patents protecting this investigational drug and five international patents.

Recent Clinical Trials for Amdoxovir
TitleSponsorPhase
A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced SubjectsRFS Pharma, LLCPhase 2
A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.RFS Pharma, LLCPhase 2
Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIVRFS Pharma, LLCPhase 1/Phase 2

See all Amdoxovir clinical trials

Clinical Trial Summary for Amdoxovir

Top disease conditions for Amdoxovir
Top clinical trial sponsors for Amdoxovir

See all Amdoxovir clinical trials

US Patents for Amdoxovir

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Amdoxovir   Start Trial Pharmaceutical antiretroviral composition Cipla Limited (Mumbai, IN)   Start Trial
Amdoxovir   Start Trial Method of preparing carboxylic acid functionalized polymers NEKTAR THERAPEUTICS (San Francisco, CA)   Start Trial
Amdoxovir   Start Trial Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same STC.UNM (Albuquerque, NM) Sandia Corporation (Albuquerque, NM)   Start Trial
Amdoxovir   Start Trial Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections EMORY UNIVERSITY (Atlanta, GA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Amdoxovir

Drugname Country Document Number Estimated Expiration Related US Patent
Amdoxovir Australia 2013336491 1989-12-31   Start Trial
Amdoxovir Brazil 112015006558 1989-12-31   Start Trial
Amdoxovir Canada 2885763 1989-12-31   Start Trial
Amdoxovir China 104884063 1989-12-31   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Express Scripts
McKinsey
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.